Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Planning and Dissemination Grant - Institute Community Support

Ottawa Hospital Research Institute

$20,000.00

2024 Canadian-Natural Killer Cell Consortium annual symposium: Contract killers for human health.

EF 2023-24

Résumé
Natural Killer cells are essential components of our immune system involved in clearing cancer and infections. Canada can count on a vibrant and internationally renowned community of scientists interested in better understanding NK cells and translating basic discoveries in NK cell biology into the clinic. The Canadian Natural Killer Cell Consortium is an avenue to connect these Canadian researchers with a mission to foster collaborations, highlight cutting-edge research and promote specialized training in NK cell biology. To this end, our annual meeting plays a fundamental in achieving CanNKC's mission, as it allows for face-to-face interactions between researchers spread across the whole country. On June 13-14, 2024 we will gather scientists, medical doctors, trainees and patients interested in knowing more about the role played by NK cells in cancer, infectious diseases and transplant rejection. World-renowned international experts will be invited to deliver keynote lectures that will be followed by trainees presenting their work. Trainees and patients will also have a chance to engage with senior researchers and industry professionals thanks to several activities organized to foster networking. We believe that sharing this knowledge and expertise will be critical to our goal to promote basic discoveries that will translate the potential of killer immune cells into the clinic.
Programme
Planning and Dissemination Grant - Institute Community Support
Emplacement
Ontario, Canada
Type de bénéficiaire
Other
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
499129
Name
Ardolino Michele
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Planning and Dissemination Grants
Projecttitle
2024 Canadian-Natural Killer Cell Consortium annual symposium: Contract killers for human health.
Programtype2
Miscellaneous Programs
Orgnameinp2
Ottawa Hospital Research Institute
Cihramount2
$20,000
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Cancer Immunotherapy; Collaborative Networking; Immunology; Industry; Infectious Diseases; Innate Immunity; Nk Cells; Student Researchers; Transplantation; Vaccines
Abstract
Natural Killer cells are essential components of our immune system involved in clearing cancer and infections. Canada can count on a vibrant and internationally renowned community of scientists interested in better understanding NK cells and translating basic discoveries in NK cell biology into the clinic. The Canadian Natural Killer Cell Consortium is an avenue to connect these Canadian researchers with a mission to foster collaborations, highlight cutting-edge research and promote specialized training in NK cell biology. To this end, our annual meeting plays a fundamental in achieving CanNKC's mission, as it allows for face-to-face interactions between researchers spread across the whole country. On June 13-14, 2024 we will gather scientists, medical doctors, trainees and patients interested in knowing more about the role played by NK cells in cancer, infectious diseases and transplant rejection. World-renowned international experts will be invited to deliver keynote lectures that will be followed by trainees presenting their work. Trainees and patients will also have a chance to engage with senior researchers and industry professionals thanks to several activities organized to foster networking. We believe that sharing this knowledge and expertise will be critical to our goal to promote basic discoveries that will translate the potential of killer immune cells into the clinic.
Competitiondate
202402
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ardolino, Michele
Approvedterm
1 an 0 mois
Cihrcontribution2
III~ $20,000~ $0~